A Study of VLX1570 and Dexamethasone in Myeloma Patients

NCT02372240 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Dose limiting tox is observed. Study put on full clinical hold.

Conditions

Multiple Myeloma

Interventions

DRUG: VLX1570 and dexamethasone

Sponsor

Vivolux AB

Collaborators

[object Object]